Literature DB >> 15157263

Transfusion-transmitted hepatitis E caused by apparently indigenous hepatitis E virus strain in Hokkaido, Japan.

Keiji Matsubayashi1, Yasuhiro Nagaoka, Hidekatsu Sakata, Shinichiro Sato, Kanji Fukai, Toshiaki Kato, Kazuaki Takahashi, Shunji Mishiro, Mitsunobu Imai, Naokazu Takeda, Hisami Ikeda.   

Abstract

BACKGROUND: In industrialized countries, sporadic cases of hepatitis E have been reported in individuals who have never been in an endemic area. Hepatitis E virus (HEV) infection commonly occurs via the fecal-oral route but a potential risk of transfusion transmission route has been suggested. STUDY DESIGN AND METHODS: A 67-year-old Japanese male patient who had never been abroad received a transfusion of blood from 23 voluntary donors and developed acute hepatitis with unknown etiology after transfusion. His blood samples were tested for viral markers of hepatitis viruses.
RESULTS: HAV, HBV, HCV, CMV, and EBV were ruled out as causative agents in this case. The patient's blood sample in the acute phase contained HEV RNA as well as IgM and IgG anti-HEV. HEV RNA was also detected in one of the FFP units transfused. The donor had no history of traveling abroad and had a normal ALT level at the time of donation. The PCR products from the patient and the donor showed complete identity for two distinct regions of HEV within open reading frame 1.
CONCLUSION: The patient was infected with HEV via transfused blood from a volunteer donor. A potential risk of posttransfusion hepatitis E should be considered even in nonendemic countries.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15157263     DOI: 10.1111/j.1537-2995.2004.03300.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  67 in total

1.  Hepatitis E Virus.

Authors: 
Journal:  Transfus Med Hemother       Date:  2009       Impact factor: 3.747

Review 2.  Infectious risks associated with the transfusion of blood components and pathogen inactivation in Japan.

Authors:  Masahiro Satake
Journal:  Int J Hematol       Date:  2004-11       Impact factor: 2.490

Review 3.  Economics of pathogen inactivation technology for platelet concentrates in Japan.

Authors:  Ulf Staginnus; Laurence Corash
Journal:  Int J Hematol       Date:  2004-11       Impact factor: 2.490

4.  Transfusion-transmitted hepatitis E in a patient with myelodysplastic syndromes.

Authors:  Yukihiko Kimura; Akihiko Gotoh; Seiichiro Katagiri; Yuji Hoshi; Shigeharu Uchida; Atsushi Yamasaki; Yoko Takahashi; Katsuyuki Fukutake; Toru Kiguchi; Kazuma Ohyashiki
Journal:  Blood Transfus       Date:  2013-10-02       Impact factor: 3.443

5.  Comparative pathogenesis in specific-pathogen-free chickens of two strains of avian hepatitis E virus recovered from a chicken with Hepatitis-Splenomegaly syndrome and from a clinically healthy chicken.

Authors:  P Billam; T LeRoith; R S Pudupakam; F W Pierson; R B Duncan; X J Meng
Journal:  Vet Microbiol       Date:  2009-06-11       Impact factor: 3.293

6.  Hepatitis E Virus.

Authors:  Georg Pauli; Johannes Blümel; Reinhard Burger; Christian Drosten; Albrecht Gröner; Lutz Gürtler; Margarethe Heiden; Martin Hildebrandt; Bernd Jansen; Horst Klamm; Thomas Montag-Lessing; Ruth Offergeld; Rainer Seitz; Uwe Schlenkrich; Volkmar Schottstedt; Hannelore Willkommen; Carl-Heinz Wirsing von König
Journal:  Transfus Med Hemother       Date:  2008-01-18       Impact factor: 3.747

Review 7.  Hepatitis E: an old infection with new implications.

Authors:  Giuseppe Marano; Stefania Vaglio; Simonetta Pupella; Giuseppina Facco; Maria Bianchi; Gabriele Calizzani; Fabio Candura; Liviana Catalano; Blandina Farina; Monica Lanzoni; Vanessa Piccinini; Giancarlo M Liumbruno; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2014-09-12       Impact factor: 3.443

8.  Hepatitis e virus: current concepts and future perspectives.

Authors:  Harry R Dalton; Suzan D Pas; Richie G Madden; Annemiek A van der Eijk
Journal:  Curr Infect Dis Rep       Date:  2014-04       Impact factor: 3.725

9.  Probable transmission of hepatitis E virus (HEV) via transfusion in the United States.

Authors:  John R Ticehurst; Nora Pisanic; Michael S Forman; Carly Ordak; Christopher D Heaney; Edgar Ong; Jeffrey M Linnen; Paul M Ness; Nan Guo; Hua Shan; Kenrad E Nelson
Journal:  Transfusion       Date:  2019-01-31       Impact factor: 3.157

Review 10.  Autochthonous hepatitis e virus infections: a new transfusion-associated risk?

Authors:  Jens Dreier; David Juhl
Journal:  Transfus Med Hemother       Date:  2013-12-30       Impact factor: 3.747

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.